Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by 9mmmmon Dec 02, 2004 4:32pm

246 Views

Post# 8261479

RE: Shareholder Revolt

Bilosellhi I agree with your post --01:54 this morning. Between my family and friends, we hold close to 50K shares of ONC. I think I could get the owners behind our causes. Thank you and others for the efforts. It really pi____ me off last week to be told by ONC that the glio trials were still enroling ( a mis truth ?) and that we would hear ???. The first patient was injected July 02 - - some results Dec 02. No news now for TWO YEARS on the glio trials - - appaling. And the worst is that the company has never attempted to explain why they find it necessary to withhold information from us - - the owners.

Bullboard Posts

Three high-conviction small-cap stocks across the risk spectrum